These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 25596108)

  • 21. Principal component analysis-based pattern analysis of dose-volume histograms and influence on rectal toxicity.
    Söhn M; Alber M; Yan D
    Int J Radiat Oncol Biol Phys; 2007 Sep; 69(1):230-9. PubMed ID: 17707277
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dynamics of rectal balloon implant shrinkage in prostate VMAT : Influence on anorectal dose and late rectal complication risk.
    Vanneste BGL; van Wijk Y; Lutgens LC; Van Limbergen EJ; van Lin EN; van de Beek K; Lambin P; Hoffmann AL
    Strahlenther Onkol; 2018 Jan; 194(1):31-40. PubMed ID: 29038832
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationships between DVHs and late rectal bleeding after radiotherapy for prostate cancer: analysis of a large group of patients pooled from three institutions.
    Fiorino C; Cozzarini C; Vavassori V; Sanguineti G; Bianchi C; Cattaneo GM; Foppiano F; Magli A; Piazzolla A
    Radiother Oncol; 2002 Jul; 64(1):1-12. PubMed ID: 12208568
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Lateral rectal shielding reduces late rectal morbidity following high dose three-dimensional conformal radiation therapy for clinically localized prostate cancer: further evidence for a significant dose effect.
    Lee WR; Hanks GE; Hanlon AL; Schultheiss TE; Hunt MA
    Int J Radiat Oncol Biol Phys; 1996 May; 35(2):251-7. PubMed ID: 8635930
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modelling late stool frequency and rectal pain after radical radiotherapy in prostate cancer patients: Results from a large pooled population.
    Cicchetti A; Rancati T; Ebert M; Fiorino C; Palorini F; Kennedy A; Joseph DJ; Denham JW; Vavassori V; Fellin G; Avuzzi B; Stucchi C; Valdagni R
    Phys Med; 2016 Dec; 32(12):1690-1697. PubMed ID: 27720692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Patterns in ano-rectal dose maps and the risk of late toxicity after prostate IMRT.
    Onjukka E; Fiorino C; Cicchetti A; Palorini F; Improta I; Gagliardi G; Cozzarini C; Degli Esposti C; Gabriele P; Valdagni R; Rancati T
    Acta Oncol; 2019 Dec; 58(12):1757-1764. PubMed ID: 31298076
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical effect of multileaf collimator width on the incidence of late rectal bleeding after high-dose intensity-modulated radiotherapy for localized prostate carcinoma.
    Inokuchi H; Mizowaki T; Norihisa Y; Takayama K; Ikeda I; Nakamura K; Nakamura M; Hiraoka M
    Int J Clin Oncol; 2016 Feb; 21(1):156-61. PubMed ID: 26164689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Rectal dose-volume constraints in high-dose radiotherapy of localized prostate cancer.
    Fiorino C; Sanguineti G; Cozzarini C; Fellin G; Foppiano F; Menegotti L; Piazzolla A; Vavassori V; Valdagni R
    Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):953-62. PubMed ID: 14575825
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gastrointestinal toxicity and its relation to dose distributions in the anorectal region of prostate cancer patients treated with radiotherapy.
    Heemsbergen WD; Hoogeman MS; Hart GA; Lebesque JV; Koper PC
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(4):1011-8. PubMed ID: 15752880
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-volume analysis of predictors for chronic rectal toxicity after treatment of prostate cancer with adaptive image-guided radiotherapy.
    Vargas C; Martinez A; Kestin LL; Yan D; Grills I; Brabbins DS; Lockman DM; Liang J; Gustafson GS; Chen PY; Vicini FA; Wong JW
    Int J Radiat Oncol Biol Phys; 2005 Aug; 62(5):1297-308. PubMed ID: 16029785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Conformal irradiation of the prostate: estimating long-term rectal bleeding risk using dose-volume histograms.
    Hartford AC; Niemierko A; Adams JA; Urie MM; Shipley WU
    Int J Radiat Oncol Biol Phys; 1996 Oct; 36(3):721-30. PubMed ID: 8948358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Significant correlation between rectal DVH and late bleeding in patients treated after radical prostatectomy with conformal or conventional radiotherapy (66.6-70.2 Gy).
    Cozzarini C; Fiorino C; Ceresoli GL; Cattaneo GM; Bolognesi A; Calandrino R; Villa E
    Int J Radiat Oncol Biol Phys; 2003 Mar; 55(3):688-94. PubMed ID: 12573756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gastro-intestinal and genito-urinary morbidity after 3D conformal radiotherapy of prostate cancer: observations of a randomized trial.
    Koper PC; Jansen P; van Putten W; van Os M; Wijnmaalen AJ; Lebesque JV; Levendag PC
    Radiother Oncol; 2004 Oct; 73(1):1-9. PubMed ID: 15465140
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differences in radiation dosimetry and anorectal function testing imply that anorectal symptoms may arise from different anatomic substrates.
    Smeenk RJ; Hopman WP; Hoffmann AL; van Lin EN; Kaanders JH
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):145-52. PubMed ID: 20950951
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Volume and hormonal effects for acute side effects of rectum and bladder during conformal radiotherapy for prostate cancer.
    Peeters ST; Hoogeman MS; Heemsbergen WD; Slot A; Tabak H; Koper PC; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1142-52. PubMed ID: 15939547
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Impact of mean rectal dose on late rectal bleeding after conformal radiotherapy for prostate cancer: dose-volume effect.
    Zapatero A; García-Vicente F; Modolell I; Alcántara P; Floriano A; Cruz-Conde A; Torres JJ; Pérez-Torrubia A
    Int J Radiat Oncol Biol Phys; 2004 Aug; 59(5):1343-51. PubMed ID: 15275719
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients.
    Wortel RC; Incrocci L; Pos FJ; Lebesque JV; Witte MG; van der Heide UA; van Herk M; Heemsbergen WD
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):737-44. PubMed ID: 25752386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relationships between rectal and perirectal doses and rectal bleeding or tenesmus in pooled voxel-based analysis of 3 randomised phase III trials.
    Marcello M; Denham JW; Kennedy A; Haworth A; Steigler A; Greer PB; Holloway LC; Dowling JA; Jameson MG; Roach D; Joseph DJ; Gulliford SL; Dearnaley DP; Sydes MR; Hall E; Ebert MA
    Radiother Oncol; 2020 Sep; 150():281-292. PubMed ID: 32745667
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Disturbed colonic motility contributes to anorectal symptoms and dysfunction after radiotherapy for carcinoma of the prostate.
    Yeoh EK; Bartholomeusz DL; Holloway RH; Fraser RJ; Botten R; Di Matteo A; Moore JW; Schoeman MN
    Int J Radiat Oncol Biol Phys; 2010 Nov; 78(3):773-80. PubMed ID: 20153122
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dose-volume response analyses of late rectal bleeding after radiotherapy for prostate cancer.
    Tucker SL; Cheung R; Dong L; Liu HH; Thames HD; Huang EH; Kuban D; Mohan R
    Int J Radiat Oncol Biol Phys; 2004 Jun; 59(2):353-65. PubMed ID: 15145148
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.